Raras
Buscar doenças, sintomas, genes...
Disgenesia gonadal parcial 46,XY
ORPHA:251510CID-10 · Q56.1CID-11 · LD2A.1DOENÇA RARA

A disgenesia gonadal parcial 46,XY (PGD 46,XY) é um distúrbio do desenvolvimento sexual (DSD) associado a anomalias no desenvolvimento gonadal que resulta em ambiguidade genital de grau variável, variando de fenótipo quase feminino a fenótipo quase masculino em um paciente portador de cariótipo 46,XY masculino.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A disgenesia gonadal parcial 46,XY (PGD 46,XY) é um distúrbio do desenvolvimento sexual (DSD) associado a anomalias no desenvolvimento gonadal que resulta em ambiguidade genital de grau variável, variando de fenótipo quase feminino a fenótipo quase masculino em um paciente portador de cariótipo 46,XY masculino.

Publicações científicas
1 artigos
Último publicado: 2022 Dec 28

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q56.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
11 sintomas
😀
Face
6 sintomas
🫘
Rins
6 sintomas
🧬
Pele e cabelo
3 sintomas
🦴
Ossos e articulações
3 sintomas
🫃
Digestivo
2 sintomas

+ 48 sintomas em outras categorias

Características mais comuns

90%prev.
Disgenesia gonadal
Muito frequente (99-80%)
90%prev.
Ovário em fita
Muito frequente (99-80%)
90%prev.
Genitália interna anormal
Muito frequente (99-80%)
90%prev.
Ginecomastia
Muito frequente (99-80%)
90%prev.
Anormalidade do escroto
Muito frequente (99-80%)
90%prev.
Azoospermia
Muito frequente (99-80%)
84sintomas
Muito frequente (31)
Frequente (3)
Ocasional (6)
Muito raro (3)
Sem dados (41)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 84 características clínicas mais associadas, ordenadas por frequência.

Disgenesia gonadalGonadal dysgenesis
Muito frequente (99-80%)90%
Ovário em fitaStreak ovary
Muito frequente (99-80%)90%
Genitália interna anormalAbnormal internal genitalia
Muito frequente (99-80%)90%
GinecomastiaGynecomastia
Muito frequente (99-80%)90%
Anormalidade do escrotoAbnormality of the scrotum
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa4desde 2022
Total histórico1PubMed
Últimos 10 anos1publicações
Pico20221 papers
Linha do tempo
2022Hoje · 2026🧪 2010Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

11 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive, Y-linked.

DHX37Probable ATP-dependent RNA helicase DHX37Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-binding RNA helicase that plays a role in maturation of the small ribosomal subunit in ribosome biogenesis (PubMed:30582406). Required for the release of the U3 snoRNP from pre-ribosomal particles (PubMed:30582406). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and wor

LOCALIZAÇÃO

Nucleus, nucleolusCytoplasmNucleus membrane

VIAS BIOLÓGICAS (2)
rRNA modification in the nucleus and cytosolMajor pathway of rRNA processing in the nucleolus and cytosol
MECANISMO DE DOENÇA

Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies

An autosomal recessive neurodevelopmental disorder characterized by severe developmental delay, impaired intellectual development, hypotonia, brain anomalies including cortical volume loss, corpus callosum dysgenesis and cerebellar hypoplasia, and variable dysmorphic features. Patients may have platyspondyly, scoliosis, and cardiac anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.9 TPM
Fibroblastos
19.3 TPM
Ovário
19.0 TPM
Útero
18.1 TPM
Nervo tibial
17.0 TPM
OUTRAS DOENÇAS (4)
neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies46,XY sex reversal 1146,XY complete gonadal dysgenesis46,XY partial gonadal dysgenesis
HGNC:17210UniProt:Q8IY37
ZFPM2Zinc finger protein ZFPM2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription regulator that plays a central role in heart morphogenesis and development of coronary vessels from epicardium, by regulating genes that are essential during cardiogenesis. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA4, GATA5 and GATA6. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. Also required in gonadal differentiation, possibly be regulatin

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Transcriptional regulation of testis differentiationFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Tetralogy of Fallot

A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.2 TPM
Cerebelo
27.3 TPM
Ovário
27.0 TPM
Fallopian Tube
17.6 TPM
Útero
16.3 TPM
OUTRAS DOENÇAS (5)
tetralogy of fallot46,XY sex reversal 9diaphragmatic hernia 3congenital diaphragmatic hernia
HGNC:16700UniProt:Q8WW38
WT1Wilms tumor proteinCandidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor that plays an important role in cellular development and cell survival (PubMed:7862533). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3' (PubMed:17716689, PubMed:25258363, PubMed:7862533). Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may a

LOCALIZAÇÃO

NucleusNucleus, nucleolusCytoplasmNucleus speckleNucleus, nucleoplasm

VIAS BIOLÓGICAS (3)
Nephron developmentNegative Regulation of CDH1 Gene TranscriptionTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Frasier syndrome

Characterized by a slowly progressing nephropathy leading to renal failure in adolescence or early adulthood, male pseudohermaphroditism, and no Wilms tumor. As for histological findings of the kidneys, focal glomerular sclerosis is often observed. There is phenotypic overlap with Denys-Drash syndrome. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
109.7 TPM
Fallopian Tube
75.2 TPM
Ovário
65.2 TPM
Testículo
40.5 TPM
Adipose Visceral Omentum
30.0 TPM
OUTRAS DOENÇAS (12)
Wilms tumor 1nephrotic syndrome, type 4Meacham syndromemalignant mesothelioma
HGNC:12796UniProt:P19544
SRYSex-determining region Y proteinDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Transcriptional regulator that controls a genetic switch in male development (PubMed:11563911). It is necessary and sufficient for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (PubMed:16414182, PubMed:16996051). Involved in different aspects of gene regulation including promoter activation or repression (PubMed:9525897). Binds to the DNA consensus sequence 5'-[AT]AACAA[AT]-3' (PubMed:115639

LOCALIZAÇÃO

Nucleus speckleCytoplasmNucleus

VIAS BIOLÓGICAS (2)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY sex reversal 1

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. Patients manifest rapid and early degeneration of their gonads, which are present in the adult as 'streak gonads', consisting mainly of fibrous tissue and variable amounts of ovarian stroma. As a result these patients do not develop secondary sexual characteristics at puberty. The external genitalia in these subjects are completely female, and Muellerian structures are normal.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.5 TPM
Skin Sun Exposed Lower leg
3.4 TPM
Skin Not Sun Exposed Suprapubic
3.1 TPM
Fibroblastos
1.6 TPM
Esôfago - Mucosa
0.8 TPM
OUTRAS DOENÇAS (6)
46,XY sex reversal 145,X/46,XY mixed gonadal dysgenesis46,XY complete gonadal dysgenesis46,XX ovotesticular disorder of sex development
HGNC:11311UniProt:Q05066
VAMP7Vesicle-associated membrane protein 7Role in the phenotype ofTolerante
FUNÇÃO

Involved in the targeting and/or fusion of transport vesicles to their target membrane during transport of proteins from the early endosome to the lysosome. Required for heterotypic fusion of late endosomes with lysosomes and homotypic lysosomal fusion. Required for calcium regulated lysosomal exocytosis. Involved in the export of chylomicrons from the endoplasmic reticulum to the cis Golgi. Required for exocytosis of mediators during eosinophil and neutrophil degranulation, and target cell kill

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle membraneGolgi apparatus, trans-Golgi network membraneLate endosome membraneLysosome membraneEndoplasmic reticulum membraneCytoplasmic vesicle, phagosome membraneSynapse, synaptosome

VIAS BIOLÓGICAS (1)
Clathrin-mediated endocytosis
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
55.1 TPM
Linfócitos
52.2 TPM
Fibroblastos
50.7 TPM
Aorta
50.7 TPM
Artéria coronária
47.1 TPM
OUTRAS DOENÇAS (1)
46,XY partial gonadal dysgenesis
HGNC:11486UniProt:P51809
NR5A1Steroidogenic factor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator. Essential for sexual differentiation and formation of the primary steroidogenic tissues (PubMed:27378692). Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1 (PubMed:27378692). The SFPQ-NONO-NR5A1 complex binds to the CYP17

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
Transcriptional regulation of pluripotent stem cellsNuclear Receptor transcription pathwayTranscriptional regulation of testis differentiationSUMOylation of intracellular receptors
MECANISMO DE DOENÇA

46,XY sex reversal 3

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
221.6 TPM
Glândula adrenal
216.7 TPM
Ovário
74.6 TPM
Pituitária
33.4 TPM
Testículo
31.2 TPM
OUTRAS DOENÇAS (10)
spermatogenic failure 8premature ovarian failure 746,XX sex reversal 446,XY sex reversal 3
HGNC:7983UniProt:Q13285
GATA4Transcription factor GATA-4Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Transcriptional activator that binds to the consensus sequence 5'-AGATAG-3' and plays a key role in cardiac development and function (PubMed:24000169, PubMed:27984724, PubMed:35182466). In cooperation with TBX5, it binds to cardiac super-enhancers and promotes cardiomyocyte gene expression, while it down-regulates endocardial and endothelial gene expression (PubMed:27984724). Involved in bone morphogenetic protein (BMP)-mediated induction of cardiac-specific gene expression. Binds to BMP respons

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
Developmental Lineage of Pancreatic Acinar CellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal CellsSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)Cardiogenesis
MECANISMO DE DOENÇA

Atrial septal defect 2

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. Patients show other heart abnormalities including ventricular and atrioventricular septal defects, pulmonary valve thickening or insufficiency of the cardiac valves. The disease is not associated with defects in the cardiac conduction system or non-cardiac abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Ovário
144.1 TPM
Coração - Átrio
53.7 TPM
Testículo
51.1 TPM
Coração - Ventrículo esquerdo
45.2 TPM
Artéria coronária
40.7 TPM
OUTRAS DOENÇAS (12)
tetralogy of fallotventricular septal defect 1testicular anomalies with or without congenital heart diseaseatrial septal defect 2
HGNC:4173UniProt:P43694
MAP3K1Mitogen-activated protein kinase kinase kinase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (5)
FCERI mediated MAPK activationTRAF6 mediated NF-kB activationMyD88:MAL(TIRAP) cascade initiated on plasma membraneTRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activationMyD88 cascade initiated on plasma membrane
MECANISMO DE DOENÇA

46,XY sex reversal 6

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
37.2 TPM
Skin Sun Exposed Lower leg
36.7 TPM
Tireoide
29.7 TPM
Baço
26.1 TPM
Vagina
21.2 TPM
OUTRAS DOENÇAS (3)
46,XY sex reversal 646,XY partial gonadal dysgenesis46,XY complete gonadal dysgenesis
HGNC:6848UniProt:Q13233
WWOXWW domain-containing oxidoreductaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm

LOCALIZAÇÃO

CytoplasmNucleusMitochondrionGolgi apparatusLysosome

VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
SOX9Transcription factor SOX-9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor that plays a key role in chondrocytes differentiation and skeletal development (PubMed:24038782). Specifically binds the 5'-ACAAAG-3' DNA motif present in enhancers and super-enhancers and promotes expression of genes important for chondrogenesis, including cartilage matrix protein-coding genes COL2A1, COL4A2, COL9A1, COL11A2 and ACAN, SOX5 and SOX6 (PubMed:8640233). Also binds to some promoter regions (By similarity). Plays a central role in successive steps of chondrocyte

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (7)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation by RUNX2Transcriptional regulation of testis differentiationTranscriptional and post-translational regulation of MITF-M expression and activityDevelopmental Lineage of Multipotent Pancreatic Progenitor Cells
MECANISMO DE DOENÇA

Campomelic dysplasia

A rare, often lethal, osteochondrodysplasia characterized by congenital bowing and angulation of long bones. Other skeletal defects include unusually small scapula, deformed pelvis and spine, and a missing pair of ribs. Craniofacial and ear defects are common. Most patients die soon after birth due to respiratory distress which has been attributed to hypoplasia of the tracheobronchial cartilage and small thoracic cage. Up to two-thirds of affected XY individuals have genital defects or may develop as phenotypic females.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
110.7 TPM
Testículo
66.8 TPM
Brain Caudate basal ganglia
47.5 TPM
Cérebro - Amígdala
42.6 TPM
Córtex cerebral
42.6 TPM
OUTRAS DOENÇAS (8)
campomelic dysplasia46,XX sex reversal 246,XY sex reversal 1046,XY complete gonadal dysgenesis
HGNC:11204UniProt:P48436
NR0B1Nuclear receptor subfamily 0 group B member 1Role in the phenotype ofAltamente restrito
FUNÇÃO

Nuclear receptor that lacks a DNA-binding domain and acts as a corepressor that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions (PubMed:12482977, PubMed:32433991). Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis (PubMed:7990953, PubMed:8675564). May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Adrenal hypoplasia, congenital

A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
42.5 TPM
Testículo
39.1 TPM
Ovário
4.8 TPM
Pituitária
3.5 TPM
Cervix Ectocervix
2.9 TPM
OUTRAS DOENÇAS (5)
X-linked adrenal hypoplasia congenita46,XY sex reversal 246,XY complete gonadal dysgenesis46,XX testicular disorder of sex development
HGNC:7960UniProt:P51843

Variantes genéticas (ClinVar)

1,871 variantes patogênicas registradas no ClinVar.

🧬 DHX37: NM_032656.4(DHX37):c.2052T>G (p.Tyr684Ter) ()
🧬 DHX37: NM_032656.4(DHX37):c.3157G>A (p.Asp1053Asn) ()
🧬 DHX37: NM_032656.4(DHX37):c.1337G>A (p.Arg446Gln) ()
🧬 DHX37: GRCh37/hg19 12q23.1-24.33(chr12:99532287-133777902)x3 ()
🧬 DHX37: GRCh37/hg19 12q24.21-24.33(chr12:116422123-133777902)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 4 variantes classificadas pelo ClinVar.

4
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
SOS1: NM_005633.4(SOS1):c.406T>C (p.Tyr136His) [Likely pathogenic]
NR5A1: NM_004959.5(NR5A1):c.991-1G>C [Pathogenic]
OTX2: NM_021728.4(OTX2):c.425C>G (p.Pro142Arg) [Conflicting classifications of pathogenicity]
PROP1: NM_006261.5(PROP1):c.301_302del (p.Leu102fs) [Pathogenic/Likely pathogenic]

Vias biológicas (Reactome)

35 vias biológicas associadas aos genes desta condição.

rRNA modification in the nucleus and cytosol Major pathway of rRNA processing in the nucleolus and cytosol Transcriptional regulation of testis differentiation Factors involved in megakaryocyte development and platelet production Negative Regulation of CDH1 Gene Transcription Nephron development Deactivation of the beta-catenin transactivating complex trans-Golgi Network Vesicle Budding Lysosome Vesicle Biogenesis Golgi Associated Vesicle Biogenesis Cargo recognition for clathrin-mediated endocytosis Clathrin-mediated endocytosis Interleukin-12 signaling Nuclear Receptor transcription pathway SUMOylation of intracellular receptors Transcriptional regulation of pluripotent stem cells YAP1- and WWTR1 (TAZ)-stimulated gene expression Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Physiological factors Cardiogenesis Formation of lateral plate mesoderm Formation of definitive endoderm Developmental Lineage of Pancreatic Acinar Cells Developmental Lineage of Pancreatic Ductal Cells Developmental Lineage of Multipotent Pancreatic Progenitor Cells MyD88:MAL(TIRAP) cascade initiated on plasma membrane FCERI mediated MAPK activation TRAF6 mediated NF-kB activation TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation MyD88 cascade initiated on plasma membrane Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors Transcriptional regulation by RUNX2 Transcriptional and post-translational regulation of MITF-M expression and activity

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Disgenesia gonadal parcial 46,XY

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Disgenesia gonadal parcial 46,XY.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Disgenesia gonadal parcial 46,XY

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Novel Look at Dosage-Sensitive Sex Locus Xp21.2 in a Case of 46,XY Partial Gonadal Dysgenesis without NR0B1 Duplication.
    International journal of molecular sciences· 2022· PMID 36613932mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:251510(Orphanet)
  2. MONDO:0016674(MONDO)
  3. GARD:17211(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q56013871(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Disgenesia gonadal parcial 46,XY
Compêndio · Raras BR

Disgenesia gonadal parcial 46,XY

ORPHA:251510 · MONDO:0016674
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive, Y-linked
CID-10
Q56.1 · Pseudo-hermafroditismo masculino, não classificado em outra parte
CID-11
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4510744
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades